Open AccessEVALUATION COMPARISON BETWEEN SINOVAC AND PFIZER VACCINE AMONG INDONESIAN CHILDREN AND TEENAGER UNDER 18 YEARS OLD
Author(s) -
AZZAHROTUL QONA’AH IBNATUS SUTARDI,
Diana Laila Ramatillah
Publication year - 2022
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2022.v14s2.44745
Subject(s) - indonesian , medicine , observational study , vaccination , pediatrics , stratified sampling , demography , immunology , philosophy , linguistics , pathology , sociology
Objective: To evaluate the comparison between the Sinovac vaccine and Pfizer vaccine for children and teenagers under 18 y in Indonesia and other factors that influence it.
Methods: The type of this research is observational with a cross-sectional design using convenience sampling for all children and teenager in Indonesia who has received the full dose of Sinovac and Pfizer vaccine.
Results: It was found that the efficacy for Sinovac and Pfizer vaccines was 99.5% and 99.75%, respectively. Other factors that influence the side effects and efficacy of vaccines are gender, age, and BMI, with a p-value of each variable<0.05.
Conclusion: There is a correlation between the type of vaccine, gender, age, and BMI with the efficacy and side effects of vaccination.